| Therapeutic Tumor Infiltrating Lymphocytes studied in …STUDIED_INderived50 of 50show fewer |
|---|
| → studied in | NCT05681780Phase 1 · recruiting Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC · 50 trials list this drug (16 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04943913early Phase 1 · recruiting Study of GC101 TIL in Brain Glioma (Soochow2) · 50 trials list this drug (16 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04960072early Phase 1 · recruiting A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital) · 50 trials list this drug (16 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04967833early Phase 1 · recruiting A Study of GC101 TIL in Advanced Solid Tumors (TR) · 50 trials list this drug (16 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05087745early Phase 1 · recruiting A Clinical Study on TIL for the Treatment of Advanced Solid Tumors · 50 trials list this drug (16 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647068Phase 2 · not yet recruiting Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors · 50 trials list this drug (16 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628894Phase 1 · not yet recruiting Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy · 50 trials list this drug (16 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03467516Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma · 50 trials list this drug (16 active) | — | — | Uveal Neoplasm,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801083Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers · 50 trials list this drug (16 active) | — | — | Malignant Biliary Tract Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935893Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers · 50 trials list this drug (16 active) | — | — | Malignant Mesothelioma,Sarcoma,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04426669Phase 1/Phase 2 · completed A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering · 50 trials list this drug (16 active) | — | — | Digestive System Neoplasm,Malignant Digestive System Neoplasm,Malignant Esophageal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06626256Phase 1 · withdrawn STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma · 50 trials list this drug (16 active) | — | — | Malignant Solid Neoplasm,Melanoma,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142475early Phase 1 · recruiting A Study of GC101 TIL in Advanced Breast Cancer (10hospital) · 50 trials list this drug (16 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04611126Phase 1/Phase 2 · terminated T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer · 50 trials list this drug (16 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02500576Phase 2 · completed Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532799Phase 1/Phase 2 · recruiting TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer · 50 trials list this drug (16 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532812Phase 1/Phase 2 · recruiting TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer · 50 trials list this drug (16 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06530303Phase 1/Phase 2 · recruiting Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer · 50 trials list this drug (16 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06640582Phase 1/Phase 2 · recruiting TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas · 50 trials list this drug (16 active) | — | — | Glioblastoma,Glioma,Meningioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06538012Phase 1/Phase 2 · recruiting TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer · 50 trials list this drug (16 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863330Phase 2 · terminated Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04766320Phase 1 · unknown Study on TIL for the Treatment of r/r Gynecologic Tumors · 50 trials list this drug (16 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06107894Phase 1 · unknown TIL Therapy for Patients With Advanced Solid Tumors · 50 trials list this drug (16 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05649618early Phase 1 · unknown TIL Cells for the Treatment of the Advanced Solid Tumors Patients · 50 trials list this drug (16 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807182Phase 2 · completed Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526185early Phase 1 · terminated A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05333588early Phase 1 · unknown The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. · 50 trials list this drug (16 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375984Phase 2 · terminated A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072263Phase 1/Phase 2 · unknown Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer · 50 trials list this drug (16 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03158935Phase 1 · completed The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial · 50 trials list this drug (16 active) | — | — | Melanoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01369875Phase 2 · terminated Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01883323Phase 2 · completed Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046852Phase 1/Phase 2 · completed Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma · 50 trials list this drug (16 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00604136Phase 2 · unknown Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062036Phase 1/Phase 2 · completed Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096382Phase 2 · completed Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019357Phase 1 · completed Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy · 50 trials list this drug (16 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301730Phase 1 · completed Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung · 50 trials list this drug (16 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01369888Phase 1/Phase 2 · terminated Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006113Phase 2 · terminated Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003780Phase 2 · unknown Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas · 50 trials list this drug (16 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002535Phase 2 · completed Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019084Phase 2 · completed Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer · 50 trials list this drug (16 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002572Phase 1 · completed Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors · 50 trials list this drug (16 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003665Phase 1 · completed Vaccine Therapy in Treating Patients With Stage IV Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085462Phase 1 · completed Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091104Phase 1 · completed Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002733Phase 2 · completed Biological Therapy in Treating Patients With Metastatic Cancer · 50 trials list this drug (16 active) | — | — | Adult Solid Neoplasm,Melanoma,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002786Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045149Phase 1 · completed Biological Therapy in Treating Patients With Metastatic Melanoma · 50 trials list this drug (16 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |